Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
December 29 2022 - 5:00AM
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia
management company focused on improving the way cardiac arrhythmias
are diagnosed and treated, today announced the acceptance of the
AcQForce Flutter abstract titled “AcQForce Flutter Trial Clinical
Results: Force Sensing RF Ablation with Low Flow Gold Tip Catheter
for Typical Flutter” for presentation during the Late-Breaking
Clinical Trials and First Report Investigations session at the AF
Symposium in Boston. This abstract – including full study results -
will be presented on Friday, February 3, 2023.
The AcQForce Flutter clinical study was submitted to the FDA as
part of Acutus’ PMA submission for the AcQBlate Force Sensing
Ablation Catheter, the only force-sensing ablation catheter with a
gold tip electrode, and System. The irrigated gold tip ablation
catheter has 4x thermal conductivity compared to platinum
catheters, which allows for significantly more energy delivery at a
lower temperature and requires less saline flow.1 This is the first
PMA submission by Acutus and the first time the company is
presenting at a Late-Breaking Clinical Trials session.
To learn more about Acutus Medical’s complete portfolio of
diagnostic, access and therapy products, please visit
https://acutusmedical.com.
References1. Linhart M. et al., Superiority of
Gold Compared to Platinum Tip Irrigated Catheter Ablation of the
Pulmonary Veins and the Cavotricuspid Isthmus: A Randomized Study
Comparing Tip Temperatures and Cooling Flow Requirements. J
Cardiovasc Electrophysiol. 2012 Jul; 23(7): 717–21
About Acutus MedicalAcutus Medical is an
arrhythmia management company focused on improving the way cardiac
arrhythmias are diagnosed and treated. Acutus is committed to
advancing the field of electrophysiology with a unique array of
products and technologies which will enable more physicians to
treat more patients more efficiently and effectively. Through
internal product development, acquisitions and global partnerships,
Acutus has established a global sales presence delivering a broad
portfolio of highly differentiated electrophysiology products that
provide its customers with a complete solution for catheter-based
treatment of cardiac arrhythmias. Founded in 2011, Acutus is based
in Carlsbad, California.
About AF SymposiumThe AF Symposium is an
intensive three-day symposium that brings together the world's
leading medical scientists to share, in a highly interactive
environment, the most recent advances in the field of atrial
fibrillation. The AF Symposium was initiated in 1995 in response to
the growing epidemic of atrial fibrillation. Over the past 28
years, the meeting has become a major scientific forum at which
health care professionals have a unique opportunity to learn about
advances in research and therapeutics directly from many of the
most eminent investigators in the field.
Follow Acutus Medical on: Twitter, LinkedIn,
YouTube and Facebook.
Investor ContactCaroline Corner
415-202-5678caroline.corner@westwicke.com
Media Contact Peter
Neems442-232-6094peter.neems@acutus.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Apr 2024 to May 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From May 2023 to May 2024